GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BML Inc (OTCPK:BMLKF) » Definitions » Cyclically Adjusted PS Ratio

BML (BMLKF) Cyclically Adjusted PS Ratio : 0.90 (As of May. 22, 2024)


View and export this data going back to 2009. Start your Free Trial

What is BML Cyclically Adjusted PS Ratio?

As of today (2024-05-22), BML's current share price is $12.675. BML's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $14.04. BML's Cyclically Adjusted PS Ratio for today is 0.90.

The historical rank and industry rank for BML's Cyclically Adjusted PS Ratio or its related term are showing as below:

BMLKF' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.82   Med: 1.19   Max: 1.8
Current: 0.84

During the past years, BML's highest Cyclically Adjusted PS Ratio was 1.80. The lowest was 0.82. And the median was 1.19.

BMLKF's Cyclically Adjusted PS Ratio is ranked better than
78.2% of 133 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.37 vs BMLKF: 0.84

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

BML's adjusted revenue per share data for the three months ended in Dec. 2023 was $6.251. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $14.04 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


BML Cyclically Adjusted PS Ratio Historical Data

The historical data trend for BML's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BML Cyclically Adjusted PS Ratio Chart

BML Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.15 1.44 1.06 0.97 -

BML Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.97 0.90 0.85 0.90 -

Competitive Comparison of BML's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, BML's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BML's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BML's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where BML's Cyclically Adjusted PS Ratio falls into.



BML Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

BML's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=12.675/14.04
=0.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BML's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, BML's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=6.251/106.8000*106.8000
=6.251

Current CPI (Dec. 2023) = 106.8000.

BML Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 5.428 95.700 6.058
201406 6.140 98.000 6.691
201409 5.739 98.500 6.223
201412 5.229 97.900 5.704
201503 4.846 97.900 5.287
201506 5.218 98.400 5.663
201509 5.295 98.500 5.741
201512 5.395 98.100 5.873
201603 5.492 97.900 5.991
201606 6.342 98.100 6.904
201609 6.468 98.000 7.049
201612 5.718 98.400 6.206
201703 5.492 98.100 5.979
201706 6.139 98.500 6.656
201709 6.116 98.800 6.611
201712 5.975 99.400 6.420
201803 5.929 99.200 6.383
201806 6.371 99.200 6.859
201809 6.043 99.900 6.460
201812 6.335 99.700 6.786
201903 5.910 99.700 6.331
201906 6.693 99.800 7.162
201909 6.772 100.100 7.225
201912 6.645 100.500 7.062
202003 6.345 100.300 6.756
202006 5.974 99.900 6.387
202009 7.846 99.900 8.388
202012 9.105 99.300 9.793
202103 9.110 99.900 9.739
202106 10.514 99.500 11.285
202109 10.846 100.100 11.572
202112 8.881 100.100 9.475
202203 10.363 101.100 10.947
202206 7.622 101.800 7.996
202209 7.670 103.100 7.945
202212 7.582 104.100 7.779
202303 6.780 104.400 6.936
202306 6.402 105.200 6.499
202309 6.042 106.200 6.076
202312 6.251 106.800 6.251

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BML  (OTCPK:BMLKF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


BML Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of BML's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BML (BMLKF) Business Description

Traded in Other Exchanges
Address
5-21-3 Sendagaya, Shibuya-ku, Tokyo, JPN, 1510051
BML Inc provides laboratory testing services in Japan through a network of regional facilities. Its core clinical testing business provides a range of general and specialty laboratory tests, as well as microbiological tests that can be used for applications like food sanitation and environmental analysis. BML often uses automated systems to process and analyze these test samples. In addition to its clinical testing business, BML also has a medical information systems business and a genome-related business. The medical information systems business provides electronic medical charts and information systems that can be used in conjunction with its laboratory tests. The genome business provides gene analysis services.